January 21, 2025
TOPLINE: Time-restricted eating (TRE) doesn’t significantly reduce visceral adipose tissue (VAT) but leads to significant reductions in body weight compared with usual care in adults with […]
January 21, 2025
Patients with low-risk differentiated thyroid cancer show similar outcomes after 5 years regardless of whether they received radioactive iodine following total thyroidectomy, results from a randomized […]
January 17, 2025
(Reuters) -Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do not inform patients of the risks […]
January 17, 2025
TOPLINE: A more comprehensive risk score for type 2 diabetes (T2D) may predict disease onset in individuals with normal weight and A1c levels, challenging traditional risk […]
January 16, 2025
In the largest study of its kind involving a diabetic population, the use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs shows no significantly increased […]
January 15, 2025
TOPLINE: First-line empagliflozin, taken once daily for 3 months, leads to a significant reduction in weight, body mass index (BMI), and waist circumference in patients with […]
January 15, 2025
Thyroid nodules initially diagnosed on fine needle aspiration (FNA) cytology to be indeterminate rarely have a change in management after repeat FNA, suggesting little benefit in […]
January 15, 2025
TOPLINE: Glucagon prescriptions for severe hypoglycemia in Medicaid initially decreased from 2012 to 2018 but increased between 2019 and 2023 following the introduction of newer products. […]
January 14, 2025
The latest glucagon-like peptide 1 (GLP-1) receptor agonists have been heralded for their potential to not only boost weight loss and glucose control but also improve […]